VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,471,804 | +40.6% | 223,295 | +105.9% | 0.00% | +33.3% |
| Q2 2023 | $1,757,426 | -17.1% | 108,432 | -14.9% | 0.00% | -25.0% |
| Q1 2023 | $2,120,955 | +52.6% | 127,371 | -13.9% | 0.00% | +33.3% |
| Q4 2022 | $1,389,800 | +248.3% | 147,904 | +1.0% | 0.00% | +200.0% |
| Q3 2022 | $399,000 | -2.2% | 146,438 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $408,000 | -56.1% | 141,251 | +29.2% | 0.00% | -50.0% |
| Q1 2022 | $929,000 | +126.6% | 109,364 | +22.7% | 0.00% | +100.0% |
| Q4 2021 | $410,000 | -18.3% | 89,136 | +11.5% | 0.00% | 0.0% |
| Q3 2021 | $502,000 | +7.7% | 79,965 | +2.8% | 0.00% | 0.0% |
| Q2 2021 | $466,000 | +1.7% | 77,765 | +7.3% | 0.00% | 0.0% |
| Q1 2021 | $458,000 | +8.3% | 72,445 | -3.7% | 0.00% | 0.0% |
| Q4 2020 | $423,000 | +0.2% | 75,215 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $422,000 | -3.9% | 72,285 | +18.7% | 0.00% | 0.0% |
| Q2 2020 | $439,000 | +115.2% | 60,898 | +39.0% | 0.00% | 0.0% |
| Q1 2020 | $204,000 | – | 43,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |